What changed for Autism Spectrum Disorder
A plain English summary of what recently moved in the public data Voxsanity tracks for Autism Spectrum Disorder. Updated from government registries. Not medical advice.
How to read these changes: every figure on this page is the difference between two snapshots of what Voxsanity had tracked on each date. Voxsanity only began taking daily snapshots in July 2026 and is still ingesting the public registries, so a rise here is mostly our own coverage expanding rather than new research appearing. Read it as our tracked coverage growing, not as a claim about real-world research changing this fast: it overstates how much actually changed.
Comparing the two most recent snapshots, 27 July 2026 and 28 July 2026.
- Trials recruiting worldwide 310 to 314 (+4)
- Trials on record 1,924 to 1,941 (+17)
Newly subsidised on the PBS
No PBS-reviewed medicines are tracked for Autism Spectrum Disorder yet, so new PBS listings cannot be reported for it. This is a gap in what Voxsanity has mapped, not a statement that no medicines are subsidised — check the PBS directly.
Past updates
Tracking began in July 2026. Month on month changes will appear here once a second month of data has been recorded. Until then, the comparison above shows the most recent movement.
Recent trend
Weekly, most recent weeks (fills out to a monthly trend as history grows).
Recent trial results
The 30 most recent of 65 trials tracked for Autism Spectrum Disorder that have reported results to a public registry.
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
-
NCT06291246 · results posted 10 July 2026
According to the results reported on ClinicalTrials.gov, this trial involved 25 people in total — 13 in a "Family Navigation" group and 12 in an "Educational Materials" group. Within those groups, participants included both caregivers (7 and 6 respectively) and children (6 and 6 respectively). The trial was looking at how quickly children with autism received their first therapy session after diagnosis, as well as caregiver wellbeing and several measures of how the children were developing. It is worth noting that the data shows zero participants were recorded as having formally "completed" th...
-
NCT06247176 · results posted 29 May 2026
According to the results reported on ClinicalTrials.gov, this trial (NCT06247176) set out to compare how the bodies and brains of people with Autism Spectrum Disorder (ASD) and people without ASD (described as "neurotypical") respond and adapt to repeated sensory stimulation. The study planned to enrol participants into two groups. The reported data shows that only one person started and completed the trial — in the ASD group — and no participants were recorded in the neurotypical group. The reported data shows that no outcome measure results were submitted for any of the four measures the tr...
-
NCT04655326 · results posted 9 April 2026
According to the results reported on ClinicalTrials.gov, this trial (NCT04655326) enrolled 296 participants in a single treatment group, with 170 completing the study and 126 not completing it. The trial was measuring changes in autism-related symptoms, social skills, and gut (gastrointestinal) symptoms in children with autism, as assessed through parent-reported questionnaires. The reported data shows that for the main (primary) outcome — a parent-reported measure called the PGIA-Change, which asks parents to rate changes across 20 autism-related symptoms on a scale from -3 (much worse) to +...
-
NCT05009095 · results posted 23 February 2026
According to the results reported on ClinicalTrials.gov, this trial looked at a sound-based listening program called The Listening Program®, delivered through bone conduction headphones (headphones that send sound vibrations through the bones of the skull rather than through the ear canal). The trial enrolled 8 participants, all in a single group — meaning there was no comparison group. Six participants completed the trial and two did not finish. The trial was measuring changes in everyday adaptive skills, functional abilities, sensory processing, and autism-related symptoms across multiple ti...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05555615 · results posted 3 December 2025
According to the results reported on ClinicalTrials.gov, this trial enrolled 209 participants who were given pimavanserin. The trial was measuring two things: firstly, how many participants experienced new or worsening side effects after starting the treatment (called "treatment-emergent adverse events"); and secondly, how many participants showed a meaningful improvement in irritability symptoms after 52 weeks, as measured by two standardised rating scales — one completed by a parent or carer (the ABC-I, which scores irritability on a scale where higher numbers mean more severe problems) and...
-
NCT05194345 · results posted 19 November 2025
According to the results reported on ClinicalTrials.gov, this trial involved 132 participants across two main groups: 64 people in the "Autism Eats" nutrition programme and 62 people in a comparison group called "We Can! Enhanced Usual Care." Within each of these main groups, participants included 25 children, 25 parents, and a number of healthcare providers. The trial was measuring whether a nutrition programme designed for children with autism could change how much fruit and vegetables they ate, how varied their diet was, overall diet quality, and challenging mealtime behaviours. The report...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05373173 · results posted 24 August 2025
According to the results reported on ClinicalTrials.gov, this trial looked at a telehealth-based autism assessment process called TAP-P. A total of 148 participants were enrolled across two groups: 30 children were assessed by telehealth only, and 118 were assessed by telehealth followed by an in-person assessment. Of those, all 30 in the telehealth-only group and 116 of the 118 in the combined group completed the study (2 did not finish). The reported data shows that clinicians rated how certain they felt about their diagnosis on a scale of 1 to 4, where 4 means "completely certain." For the...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05523895 · results posted 24 August 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT05523895) enrolled 237 people across three groups to look at the effects of two different doses of a medicine called pimavanserin compared to a placebo (a dummy treatment with no active ingredient) in people with challenging behaviours, specifically irritability. The groups were: 78 people received placebo, 78 received a lower dose of pimavanserin, and 81 received a higher dose. By the end of the study, 74, 67, and 75 people in each group respectively had completed the trial. The primary thing being measured was a change...
Read the full trial page · View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT06023563 · results posted 12 August 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT06023563) enrolled 13 children and young people in total — 7 in a group that used virtual reality (VR) active video gaming and 6 in a group that did standard balance exercises. All 13 participants completed the study with no drop-outs. The trial was measuring balance and walking (gait) at multiple time points, comparing the two groups across several measures including body sway while standing, a structured balance assessment, and various walking measurements such as step length, stride length, step width, and the time both...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT06281171 · results posted 21 May 2025
According to the results reported on ClinicalTrials.gov, this trial enrolled 115 people in total — 58 in a "Video Library Group" and 57 in a "Flyer Library Group." The trial was comparing two different types of educational resources for building communication and relationship skills: one group received video-based materials, the other received written flyer-based materials. Participants were measured at three points in time across the study, and by the final timepoint, 52 people remained in the video group and 48 in the flyer group. The reported data shows that the main thing being measured w...
-
NCT04654117 · results posted 3 April 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT04654117) involved two groups: one made up of healthcare providers receiving a structured consultation program, and one made up of families receiving a parent-delivered program called Project ImPACT. A total of 20 providers and 21 families started the trial. Of those, 16 providers and 13 families completed it, meaning 4 providers and 8 families did not finish. The reported data shows several things were measured for the provider group. On a treatment adherence checklist scored from 0 to 100 (where higher means more closel...
-
NCT04745026 · results posted 30 March 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT04745026) enrolled 103 participants in total — 49 in the GWP42003-P (cannabidiol) group and 54 in the placebo group. Of those, 36 and 41 respectively completed the study. The trial was measuring changes in behaviour, daily living skills, and overall clinical impression in people with intellectual and developmental disabilities, using several standardised rating scales completed by caregivers and clinicians over 12 weeks. The reported data shows the following for the main (primary) outcome measures. On the Aberrant Behavio...
Read the full trial page · View reported results on ClinicalTrials.gov ↗
-
NCT04349644 · results posted 7 March 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT04349644) looked at a programme called SENSE Theatre — a theatre-based activity — for adults with autism spectrum disorder (ASD). A total of 64 people started the study across two groups: 29 were assigned to take part in SENSE Theatre straight away, and 35 were placed on a waitlist (a comparison group who waited before receiving the programme). The trial tracked whether taking part in the programme was linked to changes in things like remembering faces, social skills observed in conversation, and how participants and their...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04295512 · results posted 27 February 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT04295512) looked at a programme called "Unstuck and On Target," which is designed to support children with certain behavioural and mental health challenges. The trial involved two main groups: therapists (18 in the usual care group and 23 trained in the Unstuck and On Target programme) and children (12 in the usual care group and 22 in the Unstuck and On Target group). The study measured three main things: how acceptable, appropriate, and feasible the therapists found the programme; how closely therapists followed the prog...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04294290 · results posted 24 February 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT04294290) enrolled 12 participants, all of whom completed the study — none dropped out. The trial involved infusions of a cell-based treatment called hCT-MSC (stem cells derived from umbilical cord blood). The study was set up to track a number of specific events that researchers wanted to count and measure after the infusions were given. The reported data shows the following counts from across all 12 participants: there was 1 infusion reaction recorded in total, and its severity was rated as 1 on the CTCAE scale — a stan...
-
NCT04299464 · results posted 28 January 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT04299464) enrolled 104 people across three groups: 34 received a placebo (dummy treatment), 34 received a lower dose of alogabat (20 mg), and 36 received a higher dose of alogabat (60 mg). The trial ran for 12 weeks and was primarily measuring changes in everyday adaptive skills — things like communication, socialising, and daily living — using a standard interview-based tool called the Vineland-3, which produces a score to track an individual's progress over time. By the end of the study, 32 participants in the placebo gr...
-
NCT02675933 · results posted 9 December 2024
According to the results reported on ClinicalTrials.gov, this trial involved 63 people in total, split into two groups: 32 in a "Standard of Care" group and 31 in a "Questionnaire" group. All 63 participants completed the study, with no drop-outs recorded. The trial was measuring how satisfied parents were with their child's care, comparing those who received standard care to those who also completed a questionnaire as part of their care. The reported data shows that satisfaction was measured using something called a Likert scale — a simple numbered rating system running from 1 to 5, where a...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03569176 · results posted 23 September 2024
According to the results reported on ClinicalTrials.gov, this trial looked at a wearable smart-glasses device (referred to as "Autism Glass") designed for children with autism. The trial used a crossover design, meaning some participants used the glasses first and others acted as a comparison group before later switching over. A total of 71 children were enrolled across both groups at the start (40 in the glasses group and 31 in the comparison group), though the number who completed all stages was lower — 24 in the glasses group and 12 in the comparison group finished through to week 12. The t...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03368001 · results posted 26 August 2024
According to the results reported on ClinicalTrials.gov, this trial compared two programmes for young people — one called **SENSE Theatre** and one called **Tackling Teenage Together**. A total of 290 participants were enrolled at the start (144 in the SENSE Theatre group and 146 in the Tackling Teenage Together group). The trial was measuring things like face memory (the ability to recognise and remember faces), social communication skills, adaptive behaviours such as communication, and social interaction skills, as rated by parents and observers and measured through brain-activity tasks. Th...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05472870 · results posted 21 August 2024
According to the results reported on ClinicalTrials.gov, this trial involved 30 children diagnosed with autism spectrum disorder (ASD). All 30 participants completed the study — none dropped out. The trial used a brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS), which delivers gentle magnetic pulses to specific areas of the brain. The study measured changes in social behaviours, autism-related symptoms, attention, language, and thinking skills using a series of standard questionnaires and tests, collected at the start of the study, after treatment, and aga...
-
NCT01985308 · results posted 7 August 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT01985308) involved 28 children in total — 14 in an active treatment group (MRT-Active) and 14 in a sham (inactive/placebo-like) treatment group (MRT-SHAM). All 28 children completed the study. The trial was measuring autism symptom severity using a tool called the Childhood Autism Rating Scale, 2nd Edition (CARS2), which scores behaviours across 15 areas on a scale from 15 to 60 — where a higher score means more severe symptoms. The main question being examined was how much the CARS2 score changed from the start of the stu...
-
NCT02487082 · results posted 6 June 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT02487082) enrolled 12 participants across two groups — 4 in Group A and 8 in Group B — during an initial run-in phase. The trial was measuring behaviours related to social withdrawal, repetitive movements, and sleep in children with autism, using a set of standard questionnaires completed by parents and clinicians. By the final phase, 2 participants remained in Group A and 6 in Group B. Because this was a very small trial, the numbers below should be understood in that context. The reported data shows the following scores...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04258839 · results posted 30 May 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT04258839) involved 95 participants in total — 49 who had previously received brexpiprazole (the study drug) in an earlier trial, and 46 who had previously received a placebo (a dummy treatment). All 95 entered the main study period, and 70 completed it (39 from the prior brexpiprazole group and 31 from the prior placebo group). The trial was focused on monitoring and measuring a range of health and safety indicators while participants continued or began taking brexpiprazole. The reported data shows that across both groups...
-
NCT04772898 · results posted 18 March 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT04772898) involved 30 children in total — 15 children diagnosed with Autism Spectrum Disorder (ASD) and 15 children with typical development (meaning no ASD diagnosis). The trial was measuring three main things: social traits and behaviours (using a parent-rated questionnaire called the Social Responsiveness Scale, or SRS), balance and postural control while standing still, and how in sync the heartbeats of a child rider and a horse were during equine (horse-assisted) sessions. Twenty-nine of the 30 children completed the...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT02428205 · results posted 4 March 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT02428205) looked at whether propranolol (a medication more commonly known for heart and blood pressure conditions) might affect social functioning and related behaviours in participants. A total of 9 people were enrolled — 5 in the propranolol group and 4 in the placebo (dummy treatment) group. Of those, only 3 in the propranolol group and 2 in the placebo group completed the study, meaning this was a very small pilot trial and a notable number of participants did not finish. The reported data shows results across several...
-
NCT03459625 · results posted 13 November 2023
According to the results reported on ClinicalTrials.gov, this trial involved 118 parents in total — 60 in a Mindfulness-Based Stress Reduction (MBSR) group and 58 in a Psychoeducational Support group. Almost all participants finished the trial (59 and 58 respectively). The trial was measuring two main things: children's "externalising" behaviours (things like aggression or acting out, as rated by parents using a standard checklist) and the level of stress experienced by the parents themselves. Scores were collected at what appear to be multiple time points across the study. The reported data...
-
NCT01985022 · results posted 9 June 2023
According to the results reported on ClinicalTrials.gov, this trial (NCT01985022) involved 33 young children who had been diagnosed with, or were at risk of, autism spectrum disorder. The children were split into two groups: 16 received a group-based early social interaction (ESI) program, and 17 received a combination of individual and group ESI. The trial tracked the children across several time points, measuring their social communication skills, autism-related behaviours, developmental abilities, and everyday adaptive behaviours. By the end of the study, 12 children in the group-only arm a...
-
NCT03715153 · results posted 5 June 2023
According to the results reported on ClinicalTrials.gov, this trial (NCT03715153) looked at a medicine called bumetanide (also referred to as S95008) in children with autism. The trial had two phases: a 26-week blinded phase — where neither the participants nor the researchers knew who was receiving the medicine or a dummy tablet (placebo) — followed by a 26-week open-label phase where everyone received the active medicine. In the blinded phase, 107 children were assigned to bumetanide and 104 to placebo. The main thing the trial was measuring was change in autism-related behaviours using a ra...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04764539 · results posted 9 May 2023
According to the results reported on ClinicalTrials.gov, this trial involved six children aged 4 to 8 years, split into two groups of three. One group received speech therapy materials shown on a 2D iPad Pro screen, while the other group received the same materials through 3D virtual reality (VR) goggles and special bone-conduction headphones (which deliver sound through vibrations in the skull rather than through the ears). The trial was measuring several aspects of how the children spoke before and after the sessions, including the average length of their spoken sentences, how accurately a s...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03242772 · results posted 9 March 2022
According to the results reported on ClinicalTrials.gov, this trial (NCT03242772) involved 18 young children in total — 9 in each group. All children received a parent coaching program based on the Early Start Denver Model (ESDM), a structured approach to supporting early development. One group also received amphetamine medication, while the other received a placebo (a dummy pill with no active ingredient). The trial was measuring things like how well children engaged jointly with their parents, communication and social behaviours, attention-related symptoms, and where children directed their...
See all 65 reported results for Autism Spectrum Disorder
These are the results as reported to the registry, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
What is coming
AI generated pipeline summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to NIH funding data, public investment in Autism Spectrum Disorder research in the United States sits at a very large amount, and that investment has been rising year on year. This signals that the condition is a sustained priority for publicly funded science, and that researchers are actively pursuing new understanding and potential treatments. For patients, a growing and substantial fu...
See the full Autism Spectrum Disorder page
Not medical advice. Voxsanity republishes public government health data in plain English. These figures describe research and registry activity, not the suitability of any treatment for any person. Trial status can change; always verify current status directly with the trial site and confirm Australian availability with your doctor.